AAO 2025: New Technologies and Research Highlights
The American Academy of Ophthalmology (AAO) annual meeting in Orlando, Florida, featured new technologies and ongoing research, including the effects of GLP-1 drugs on eye health and a potential sign of cardiovascular disease.
Researchers from Massachusetts Eye and Ear analyzed electronic health records of over 17,000 patients with and without xanthelasma, finding an elevated risk of cardiovascular events (14% vs 11.8%) and higher rates of high cholesterol or lipid disorders (50% vs 38%) in the xanthelasma group.
No specific quote available in the text.
Ophthalmology Times highlights key stories from the meeting, including these research findings.
Author's summary: AAO 2025 meeting showcases new eye health research.